NCT01754181
Initial Testing of the Diabeloop Algorithm in T1D Patients on Pump Therapy Over the Prandial Period and Physical Activity. Health Services Research NCT06418880
Automated Insulin Delivery for Inpatients With Dysglycemia Treatment NCT05463744
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy Treatment NCT00308737
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes Treatment NCT00211536
Study Comparing Effectiveness of Intraperitoneal Insulin Administration to Subcutaneous Insulin Administration Treatment NCT04974528
Afrezza® INHALE-1 Study in Pediatrics Treatment NCT01697657
Frequency of Hypoglycaemic Episodes During Treatment With Insulin Detemir in Well Controlled Subjects With Type 1 Diabetes Treatment NCT01461616
Effect of NPH Insulin, Insulin Detemir and Insulin Glargine on GH-IGF-IGFBP Axis Treatment NCT00888732
A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, BIAsp70, BIAsp50 and Fast-acting Human Insulin Treatment NCT00725036
Long Term Safety Trial to Compare Insulin Treatment With Preprandial Inhaled Human Insulin to s.c. Insulin Aspart Both Combined With NPH in Subjects With Type 1 Diabetes Treatment NCT00617565
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes Treatment NCT00595374
Efficacy and Safety of Insulin Detemir in Type 1 Diabetes Treatment NCT00474045
Efficacy and Safety of Insulin Detemir Versus Neutral Protamine Hagedorn (NPH) Insulin in Pregnant Women With Type 1 Diabetes Treatment NCT00424437
Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus. Treatment NCT00435019
Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes Treatment NCT00356109
Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes Treatment NCT00312156
Comparison of Efficacy and Safety of Insulin Detemir and NPH Insulin in Children and Adolescents With Type 1 Diabetes Treatment NCT00184665
Comparison of Insulin Detemir With NPH Insulin in Type 1 Diabetes Treatment NCT00127634
Study of Human Insulin Inhalation Powder in Patients With Type 1 Diabetes Treatment NCT00071448
Insulin Aspart vs. Insulin Lispro vs. Regular Insulin in Paediatric Population Treatment NCT02518945
Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes Treatment NCT01445951
Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period Treatment NCT00542724
An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus Treatment NCT00604344
Efficacy and the Safety of Insulin Detemir in Subjects With Insulin Requiring Diabetes Treatment NCT01486940
Comparison of Insulin Detemir Plus Insulin Aspart With Insulin NPH Plus Human Soluble Insulin in Subjects With Type 1 Diabetes Treatment NCT02582814
The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM Treatment NCT00004984
The Diabetes Prevention Trial of Type 1 Diabetes (DPT-1) Prevention NCT00424333
Six Month Clinical Trial Assessing Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes Treatment NCT02059161
A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003) Treatment NCT04022993
Efficacy and Safety of Insulin RinGlar® Compared to Lantus® SoloStar® in Type 1 Diabetes Mellitus Patients Treatment NCT00605137
Safety of Insulin Detemir in Children With Type 1 Diabetes Treatment NCT00569400
Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes Treatment NCT01520818
Comparison of Biphasic Human Insulin 30 With Biphasic Insulin Aspart in Subjects With Diabetes Treatment NCT01707134
Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes Treatment NCT03220425
Evaluation of the Efficacy and Safety of Insulin Detemir Compared With That of NPH Insulin in Subjects With Type 1 Diabetes. NCT00832182
Examining the Long-term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes Treatment NCT01194882
Benefit/Risk Evaluation of Insuman Implantable Versus Insuplant Using Medtronic MiniMed Implantable Pump System in Patients With Type 1 Diabetes Treatment NCT01223131
Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. Treatment NCT00419562
Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Prevention NCT00487240
Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes Treatment NCT00191581
Local Registration Trial in China Humalog Mix 50 Treatment NCT01467323
Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes Treatment NCT00308308
Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes Treatment